Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
THE ROLE OF BIOREVITALIZATION IN ANTI-AGING THERAPIES:
ADVANCES AND PERSPECTIVES
Norqulova Khadicha Yusuf qizi
Student, Kimyo international university in Tashkent
Fayziyeva Sevara Khamratovna
Scientific supervisor, Kimyo international university in Tashkent
ABSTRACT:
Biorevitalization has emerged as a minimally invasive technique in aesthetic
dermatology aimed at restoring skin hydration and promoting dermal regeneration to
counteract signs of aging. This review synthesizes current knowledge regarding the
mechanisms of action, clinical efficacy, safety profile, and procedural techniques of
biorevitalization, with a focus on hyaluronic acid-based formulations enriched with
bioactive compounds. Clinical evidence indicates improvements in skin elasticity, texture,
and hydration following treatment, though methodological limitations in existing studies
necessitate cautious interpretation. Safety data suggest a favorable profile with primarily
mild and transient adverse effects. Key challenges include heterogeneity of products, lack of
standardized protocols, and insufficient high-quality randomized trials. Future research
directions emphasize the development of advanced biomaterials, mechanistic elucidation,
and personalized therapeutic approaches to optimize outcomes. Overall, biorevitalization
holds promise as a valuable adjunct in anti-aging therapies within cosmetology, warranting
further rigorous investigation.
Keywords:
Biorevitalization, anti-aging, aesthetic dermatology, skin rejuvenation,
hyaluronic acid, mesotherapy
Introduction
The aging process profoundly affects the skin, leading to visible changes such as loss of
elasticity, dryness, wrinkles, and thinning. These alterations are driven by both intrinsic
factors, such as genetic programming and hormonal changes, and extrinsic influences like
ultraviolet (UV) radiation, pollution, and lifestyle habits. As aesthetic medicine evolves, the
demand for minimally invasive and effective anti-aging treatments continues to grow.
Biorevitalization has emerged as a promising non-surgical technique designed to restore skin
hydration, elasticity, and structure by delivering active substances directly into the dermis.
This approach primarily utilizes hyaluronic acid (HA), often combined with vitamins, amino
acids, or antioxidants, to stimulate cellular regeneration and improve skin quality from
within.
Unlike traditional fillers that aim for volume restoration, biorevitalization focuses on
revitalizing the skin tissue itself, enhancing its natural functions. It is increasingly used as
both a standalone therapy and in combination with other aesthetic treatments such as
botulinum toxin, chemical peels, and laser procedures.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
This review aims to explore the current understanding of biorevitalization in the context of
anti-aging therapies, highlighting its mechanisms of action, clinical efficacy, safety profile,
and future potential in cosmetology.
Mechanism of Action
Biorevitalization works through the intradermal injection of biologically active substances,
most notably hyaluronic acid (HA), to restore skin hydration, stimulate collagen production,
and enhance dermal cellular activity. HA is a naturally occurring component of the
extracellular matrix with a high capacity for water retention, playing a vital role in
maintaining skin turgor and elasticity. In aged or photodamaged skin, HA levels decline,
leading to dehydration and structural deterioration. The administration of non-crosslinked or
lightly crosslinked HA replenishes these levels, improving skin hydration and elasticity
while also stimulating fibroblast activity and promoting the synthesis of collagen and elastin.
In many formulations, HA is combined with vitamins, amino acids, coenzymes, nucleotides,
and peptides, which collectively support antioxidant defense, boost cellular metabolism, and
facilitate tissue repair. Additionally, the mechanical effect of microinjections induces a mild
wound-healing response, triggering the release of growth factors and enhancing local blood
circulation through neoangiogenesis. This combined biochemical and mechanical
stimulation contributes to visible improvements in skin texture, tone, and overall
rejuvenation (Fig.1).
Fig.1. Mechanism of Action Diagram
: A schematic showing how hyaluronic acid interacts
with dermal components to stimulate collagen production and improve skin quality.
Biorevitalization Agents and Techniques
Biorevitalization protocols employ formulations primarily based on non-crosslinked or
lightly stabilized hyaluronic acid, selected for its biocompatibility, biodegradability, and
capacity to restore dermal hydration. These formulations are frequently enriched with
biologically active additives such as vitamins (notably ascorbic acid and tocopherol), amino
acids, antioxidants, coenzymes, nucleotides, and trace elements, each intended to support
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
fibroblast function, collagen synthesis, and extracellular matrix remodeling. The procedure
is performed through intradermal injection using fine-gauge needles or cannulas, with
technique selection—such as micro-papular deposition, linear threading, or mesotherapy
patterns—dependent on anatomical site, skin condition, and clinical objectives. Depth of
injection typically ranges from superficial to mid-dermis to ensure optimal diffusion and
cellular interaction. Treatment protocols are usually structured as a series of sessions
administered at regular intervals (e.g., every 2–4 weeks), often followed by maintenance
phases (Fig.2).
Fig.2. Before and After Treatment Images
: Photographs illustrating the effects of
biorevitalization on skin hydration and texture.
While biorevitalization is not intended to provide volumetric correction like traditional
dermal fillers, it functions as a regenerative intervention aimed at improving dermal quality,
elasticity, and tone. Furthermore, it is frequently used in multimodal aesthetic strategies,
enhancing the outcomes of other treatments such as botulinum toxin, microneedling, or
energy-based devices. The success of biorevitalization is contingent upon proper agent
selection, precise injection technique, and individualized treatment planning.
Clinical Evidence and Outcomes
Clinical data on biorevitalization suggest measurable improvements in skin hydration,
elasticity, texture, and overall dermal quality, particularly in patients exhibiting early to
moderate signs of cutaneous aging. Multiple observational studies and small-scale
randomized controlled trials have demonstrated that intradermal administration of
hyaluronic acid-based biorevitalizing agents leads to significant enhancement in skin
viscoelasticity, as measured by cutometry and corneometry, with improvements often
persisting for several weeks to months following a series of treatment sessions. Histological
analyses have revealed increased fibroblast density, neocollagenesis, and improved
organization of collagen and elastin fibers post-treatment, suggesting that the clinical effects
are not solely attributable to hydration but also to dermal remodeling. Moreover, some
studies report increased expression of dermal biomarkers such as type I collagen, fibronectin,
and hyaluronan synthase following treatment with specific formulations.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Fig.3. Before and After Treatment Images
: Photographs illustrating the effects of
biorevitalization on skin hydration and texture.
Patient-reported outcomes frequently indicate high satisfaction rates, with improvements in
skin brightness, firmness, and tone; however, subjective assessments are often not
corroborated by blinded evaluation, highlighting the need for standardized, objective
measurement tools (Fig.3). The heterogeneity of available products, variability in injection
techniques, and absence of large-scale, double-blind studies limit the generalizability of
current evidence. Nonetheless, the existing literature supports the efficacy of
biorevitalization as a safe and beneficial adjunctive treatment in aesthetic dermatology,
particularly when integrated into individualized anti-aging protocols.
Safety and Side Effects
Biorevitalization is generally regarded as a safe and well-tolerated procedure when
performed by trained professionals using sterile technique and appropriate formulations. The
most frequently reported adverse effects are mild, transient, and localized, including
erythema, edema, bruising, tenderness at the injection site, and, occasionally, pruritus or
papule formation, all of which typically resolve within a few days without intervention.
These effects are largely attributable to the mechanical disruption of tissue during
intradermal injection rather than the pharmacological action of the agents themselves. Rare
complications such as delayed inflammatory reactions, granuloma formation, or
hypersensitivity responses have been described in isolated case reports but are generally
associated with improper technique, use of impure or unregulated products, or patient-
specific immunological predispositions. Importantly, the non-crosslinked nature of the
hyaluronic acid used in most biorevitalization products contributes to their favorable safety
profile, as the rapid biodegradability of these molecules reduces the risk of long-term
adverse tissue reactions. Nonetheless, contraindications must be observed, including active
skin infections, autoimmune diseases, known hypersensitivity to product components,
pregnancy, and anticoagulant therapy. The risk of complications can be further minimized
through rigorous patient selection, adherence to aseptic technique, and post-procedure care
protocols. While the safety profile of biorevitalization compares favorably with other
injectable aesthetic treatments, ongoing pharmacovigilance and standardization of product
composition and injection protocols are essential to maintaining clinical safety and ensuring
reproducible outcomes.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Current Challenges and Future Directions
Despite the growing popularity and clinical use of biorevitalization in aesthetic dermatology,
several challenges hinder the full integration of this technique into evidence-based practice.
One of the primary limitations is the heterogeneity of available products, which vary widely
in their composition, concentration of hyaluronic acid, molecular weight, presence of
adjunctive bioactive compounds, and rheological properties. This lack of standardization
complicates both clinical decision-making and comparative analysis across studies.
Furthermore, the current div of evidence is largely composed of small-scale trials,
observational studies, and case series with limited methodological rigor, often lacking
control groups, blinding, or objective endpoints. There is a pressing need for high-quality,
multicenter, randomized controlled trials that employ validated assessment tools and long-
term follow-up to better define efficacy, optimal treatment protocols, and duration of effect.
From a mechanistic standpoint, while the biostimulatory effects of hyaluronic acid are
increasingly recognized, the molecular pathways underlying its interaction with fibroblasts,
immune cells, and extracellular matrix components remain incompletely understood. Future
research should also explore novel biomimetic formulations that incorporate growth factors,
stem cell-derived exosomes, or gene-activated matrices to enhance regenerative outcomes.
Additionally, as demand increases, there is a critical need for standardized training,
regulatory oversight, and clinical guidelines to ensure both safety and consistency in
outcomes. Advances in imaging, molecular diagnostics, and personalized dermatology may
further refine patient selection and treatment customization, enabling biorevitalization to
evolve from a largely empirical technique to a scientifically grounded therapeutic modality.
Conclusion.
Biorevitalization represents a promising and minimally invasive approach
within the spectrum of anti-aging therapies, leveraging the hydrating and biostimulatory
properties of hyaluronic acid and complementary bioactive compounds to enhance skin
quality and stimulate dermal regeneration. Current clinical evidence, though limited by
methodological constraints, supports its efficacy in improving skin hydration, elasticity, and
texture with a favorable safety profile. Nonetheless, significant challenges remain, including
the need for standardized product formulations, optimized treatment protocols, and robust
clinical trials to validate long-term benefits and elucidate underlying mechanisms. Future
advancements in biomaterials and personalized treatment strategies hold potential to further
enhance the therapeutic outcomes of biorevitalization, consolidating its role as an integral
component of comprehensive aesthetic dermatology. Continued interdisciplinary research
and clinical vigilance are essential to fully realize and safely implement the potential of this
regenerative modality.
REFERENCES:
1.
Fanian, F., Philippon, V., Gorj, M., et al.
(2023). Evaluation of the performance
and tolerance of the combination of an HA-based filler with Tri-Hyal technology and a skin
biorevitalizer on skin aging parameters. Clinical, Cosmetic and Investigational Dermatology,
16, 1095–1105.
https://doi.org/10.2147/CCID.S372490
2.
Wollina, U., Kocic, H., Goldman, A.
(2023). Hyaluronic Acid in Facial
Rehabilitation—A
Narrative
Review.
Cosmetics,
10(2),
61.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
3.
Issa, M. C. A., Fogaça, A., Palermo, E., et al.
(2023). Global Facial Rejuvenation
Using a New Cohesive, Highly Concentrated Hyaluronic Acid Filler: A Descriptive
Analysis of 35 Cases. Cosmetics, 10(4), 105.
https://doi.org/10.3390/cosmetics10040105
4.
Bravo, B., Correia, P., Gonçalves Junior, J. E., et al.
(2023). Benefits of topical
hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical
evidence. PMC.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078143/
5.
Allure
. (2021). What Is Hyaluronic Acid, and Why Is It in So Many Skin-Care
Products?. https://www.allure.com/story/what-is-hyaluronic-acid-skin-care
6.
StatPearls
. (2021). Hyaluronic Acid - StatPearls - NCBI Bookshelf.
